{"transactions":[{"id":5856,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10467,"kind":"person","name":"Khosla Rachna","position":1,"cik":"0001881332","reported_name":"Khosla Rachna","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Nqso (Right to Buy)","published_at":"2026-08-13T23:05:29.000Z","date":"2026-08-13","kind":"exercise","planned":false,"acquired":false,"shares":1252,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":162.6,"exercise_date":"2019-05-01","expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":1252},"source":{"system":"sec-edgar","filing":"0000318154-26-000137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000137/form4.xml","form_type":"4"}},{"id":5855,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10467,"kind":"person","name":"Khosla Rachna","position":1,"cik":"0001881332","reported_name":"Khosla Rachna","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2026-08-13T23:05:29.000Z","date":"2026-08-13","kind":"sale","planned":false,"acquired":false,"shares":1252,"price":416.4256,"value":521364.8512,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 69 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":6404,"source":{"system":"sec-edgar","filing":"0000318154-26-000137","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000137/form4.xml","form_type":"4"}},{"id":5854,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10467,"kind":"person","name":"Khosla Rachna","position":1,"cik":"0001881332","reported_name":"Khosla Rachna","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2026-08-13T23:05:29.000Z","date":"2026-08-13","kind":"exercise","planned":false,"acquired":true,"shares":1252,"price":162.6,"value":203575.2,"ownership":{"direct":true},"balance_after":7656,"source":{"system":"sec-edgar","filing":"0000318154-26-000137","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000137/form4.xml","form_type":"4"}},{"id":5853,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10467,"kind":"person","name":"Khosla Rachna","position":1,"cik":"0001881332","reported_name":"Khosla Rachna","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2026-08-13T23:05:29.000Z","date":"2026-08-11","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":412.567,"value":825134.0,"ownership":{"direct":true},"balance_after":6404,"source":{"system":"sec-edgar","filing":"0000318154-26-000137","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000137/form4.xml","form_type":"4"}},{"id":5897,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-08-13T00:04:56.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 8/7/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 45 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":5080,"source":{"system":"sec-edgar","filing":"0000318154-26-000135","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000135/form4.xml","form_type":"4"}},{"id":5995,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-11T00:24:08.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":85.1685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 460 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":7485.9046,"source":{"system":"sec-edgar","filing":"0000318154-26-000133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000133/form4.xml","form_type":"4"}},{"id":5996,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10489,"kind":"person","name":"HOLLEY CHARLES M","position":1,"cik":"0001216478","reported_name":"HOLLEY CHARLES M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-11T00:22:32.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":103.4189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 1,652 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":12990.452,"source":{"system":"sec-edgar","filing":"0000318154-26-000132","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000132/form4.xml","form_type":"4"}},{"id":5997,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10490,"kind":"person","name":"Drake Michael V","position":1,"cik":"0001938942","reported_name":"Drake Michael V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-11T00:20:01.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":63.8764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 377 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":5876.1633,"source":{"system":"sec-edgar","filing":"0000318154-26-000131","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000131/form4.xml","form_type":"4"}},{"id":6181,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10493,"kind":"person","name":"Miller Derek","position":1,"cik":"0001917312","reported_name":"Miller Derek","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Nqso (Right to Buy)","published_at":"2026-08-07T22:47:09.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":1821,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":177.46,"exercise_date":"2020-04-27","expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":1821},"source":{"system":"sec-edgar","filing":"0000318154-26-000130","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000130/form4.xml","form_type":"4"}},{"id":6180,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10493,"kind":"person","name":"Miller Derek","position":1,"cik":"0001917312","reported_name":"Miller Derek","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Nqso (Right to Buy)","published_at":"2026-08-07T22:47:09.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":2069,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":162.6,"exercise_date":"2019-05-01","expiration_date":"2027-05-02","underlying":"Common Stock","underlying_shares":2069},"source":{"system":"sec-edgar","filing":"0000318154-26-000130","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000130/form4.xml","form_type":"4"}},{"id":6179,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10493,"kind":"person","name":"Miller Derek","position":1,"cik":"0001917312","reported_name":"Miller Derek","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-08-07T22:47:09.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":1821,"price":402.5444,"value":733033.3524,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is an average price of $402.5444 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 117 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":12462,"source":{"system":"sec-edgar","filing":"0000318154-26-000130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000130/form4.xml","form_type":"4"}},{"id":6178,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10493,"kind":"person","name":"Miller Derek","position":1,"cik":"0001917312","reported_name":"Miller Derek","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-08-07T22:47:09.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":1821,"price":177.46,"value":323154.66,"ownership":{"direct":true},"balance_after":14283,"source":{"system":"sec-edgar","filing":"0000318154-26-000130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000130/form4.xml","form_type":"4"}},{"id":6177,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10493,"kind":"person","name":"Miller Derek","position":1,"cik":"0001917312","reported_name":"Miller Derek","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-08-07T22:47:09.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":2069,"price":402.5444,"value":832864.3636,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is an average price of $402.5444 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer."}],"balance_after":12462,"source":{"system":"sec-edgar","filing":"0000318154-26-000130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000130/form4.xml","form_type":"4"}},{"id":6176,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10493,"kind":"person","name":"Miller Derek","position":1,"cik":"0001917312","reported_name":"Miller Derek","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-08-07T22:47:09.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":2069,"price":162.6,"value":336419.4,"ownership":{"direct":true},"balance_after":14531,"source":{"system":"sec-edgar","filing":"0000318154-26-000130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000130/form4.xml","form_type":"4"}},{"id":6187,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Nqso (Right to Buy)","published_at":"2026-08-07T22:45:54.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2948,"derivative":{"exercise_price":177.31,"exercise_date":"2021-05-03","expiration_date":"2029-05-03","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000318154-26-000129","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000129/form4.xml","form_type":"4"}},{"id":6186,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Nqso (Right to Buy)","published_at":"2026-08-07T22:45:54.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":1970,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":177.46,"exercise_date":"2020-04-27","expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":1970},"source":{"system":"sec-edgar","filing":"0000318154-26-000129","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000129/form4.xml","form_type":"4"}},{"id":6185,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-08-07T22:45:54.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":402.1601,"value":402160.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 68 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":7340,"source":{"system":"sec-edgar","filing":"0000318154-26-000129","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000129/form4.xml","form_type":"4"}},{"id":6184,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-08-07T22:45:54.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":177.31,"value":177310.0,"ownership":{"direct":true},"balance_after":8340,"source":{"system":"sec-edgar","filing":"0000318154-26-000129","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000129/form4.xml","form_type":"4"}},{"id":6183,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-08-07T22:45:54.000Z","date":"2026-08-06","kind":"sale","planned":false,"acquired":false,"shares":1970,"price":402.1601,"value":792255.397,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options."}],"balance_after":7340,"source":{"system":"sec-edgar","filing":"0000318154-26-000129","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000129/form4.xml","form_type":"4"}},{"id":6182,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-08-07T22:45:54.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":1970,"price":177.46,"value":349596.2,"ownership":{"direct":true},"balance_after":9310,"source":{"system":"sec-edgar","filing":"0000318154-26-000129","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000129/form4.xml","form_type":"4"}},{"id":9553,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10781,"kind":"person","name":"MILES AMY E","position":1,"cik":"0001248617","reported_name":"MILES AMY E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-21T23:08:26.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 408 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":5640,"source":{"system":"sec-edgar","filing":"0000318154-26-000108","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000108/form4.xml","form_type":"4"}},{"id":9554,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10782,"kind":"person","name":"Kullman Ellen Jamison","position":1,"cik":"0001303141","reported_name":"Kullman Ellen Jamison","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-21T23:07:01.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 2,121 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":14535.9807,"source":{"system":"sec-edgar","filing":"0000318154-26-000107","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000107/form4.xml","form_type":"4"}},{"id":9555,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10783,"kind":"person","name":"Klotman Mary E.","position":1,"cik":"0002020575","reported_name":"Klotman Mary E.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-21T23:05:40.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 18 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":2211,"source":{"system":"sec-edgar","filing":"0000318154-26-000106","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000106/form4.xml","form_type":"4"}},{"id":9556,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10784,"kind":"person","name":"Jacks Tyler","position":1,"cik":"0001464237","reported_name":"Jacks Tyler","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-21T23:04:05.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 2,975 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":18284,"source":{"system":"sec-edgar","filing":"0000318154-26-000105","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000105/form4.xml","form_type":"4"}},{"id":9557,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-21T23:02:52.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 418 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":7358.7361,"source":{"system":"sec-edgar","filing":"0000318154-26-000104","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000104/form4.xml","form_type":"4"}},{"id":9558,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10489,"kind":"person","name":"HOLLEY CHARLES M","position":1,"cik":"0001216478","reported_name":"HOLLEY CHARLES M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-21T23:01:30.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,564 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":12799.0331,"source":{"system":"sec-edgar","filing":"0000318154-26-000103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000103/form4.xml","form_type":"4"}},{"id":9559,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10785,"kind":"person","name":"Garland Greg C.","position":1,"cik":"0001503107","reported_name":"Garland Greg C.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-21T22:59:44.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."}],"balance_after":13848,"source":{"system":"sec-edgar","filing":"0000318154-26-000102","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000102/form4.xml","form_type":"4"}},{"id":9560,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10786,"kind":"person","name":"ECKERT ROBERT","position":1,"cik":"0001194256","reported_name":"ECKERT ROBERT","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-21T22:58:32.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 3,943 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":26251,"source":{"system":"sec-edgar","filing":"0000318154-26-000101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000101/form4.xml","form_type":"4"}},{"id":9561,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10787,"kind":"person","name":"Druker Brian","position":1,"cik":"0001740205","reported_name":"Druker Brian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-21T22:57:24.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 408 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":8391,"source":{"system":"sec-edgar","filing":"0000318154-26-000100","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000100/form4.xml","form_type":"4"}},{"id":9562,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10490,"kind":"person","name":"Drake Michael V","position":1,"cik":"0001938942","reported_name":"Drake Michael V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-21T22:56:03.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 339 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":5774.2869,"source":{"system":"sec-edgar","filing":"0000318154-26-000099","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000099/form4.xml","form_type":"4"}},{"id":9563,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10756,"kind":"person","name":"Austin Wanda M","position":1,"cik":"0001690882","reported_name":"Austin Wanda M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-21T22:54:33.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."}],"balance_after":8018,"source":{"system":"sec-edgar","filing":"0000318154-26-000098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000098/form4.xml","form_type":"4"}},{"id":9943,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-05-12T00:17:32.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":41,"price":331.11,"value":13575.51,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 39 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":4344,"source":{"system":"sec-edgar","filing":"0000318154-26-000093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000093/form4.xml","form_type":"4"}},{"id":9944,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10834,"kind":"person","name":"Santos Esteban","position":1,"cik":"0001677950","reported_name":"Santos Esteban","relationship":{"officer":true,"officer_title":"EVP, Operations"}}],"security":"Common Stock","published_at":"2026-05-12T00:15:07.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":522,"price":331.11,"value":172839.42,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 327 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":82847,"source":{"system":"sec-edgar","filing":"0000318154-26-000092","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000092/form4.xml","form_type":"4"}},{"id":9945,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-05-12T00:07:43.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":556,"price":331.11,"value":184097.16,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 350 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":42256,"source":{"system":"sec-edgar","filing":"0000318154-26-000091","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000091/form4.xml","form_type":"4"}},{"id":9946,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10493,"kind":"person","name":"Miller Derek","position":1,"cik":"0001917312","reported_name":"Miller Derek","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-05-12T00:06:16.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":151,"price":331.11,"value":49997.61,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 99 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":12444,"source":{"system":"sec-edgar","filing":"0000318154-26-000090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000090/form4.xml","form_type":"4"}},{"id":9947,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10467,"kind":"person","name":"Khosla Rachna","position":1,"cik":"0001881332","reported_name":"Khosla Rachna","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2026-05-12T00:04:52.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":93,"price":331.11,"value":30793.23,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 59 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":8394,"source":{"system":"sec-edgar","filing":"0000318154-26-000089","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000089/form4.xml","form_type":"4"}},{"id":9948,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-05-12T00:02:51.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":88,"price":331.11,"value":29137.68,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 58 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":7330,"source":{"system":"sec-edgar","filing":"0000318154-26-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000088/form4.xml","form_type":"4"}},{"id":9949,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10836,"kind":"person","name":"Griffith Peter H.","position":1,"cik":"0001798821","reported_name":"Griffith Peter H.","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-05-12T00:01:38.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":556,"price":331.11,"value":184097.16,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 359 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":50150,"source":{"system":"sec-edgar","filing":"0000318154-26-000087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000087/form4.xml","form_type":"4"}},{"id":9950,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10837,"kind":"person","name":"Graham Jonathan P","position":1,"cik":"0001365306","reported_name":"Graham Jonathan P","relationship":{"officer":true,"officer_title":"EVP & Gen. Counsel & Sec."}}],"security":"Common Stock","published_at":"2026-05-12T00:00:04.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":499,"price":331.11,"value":165223.89,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares include 311 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":39712,"source":{"system":"sec-edgar","filing":"0000318154-26-000086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000086/form4.xml","form_type":"4"}},{"id":9951,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10838,"kind":"person","name":"Gordon Murdo","position":1,"cik":"0001642156","reported_name":"Gordon Murdo","relationship":{"officer":true,"officer_title":"EVP, Global Commercial Ops"}}],"security":"Common Stock","published_at":"2026-05-11T23:58:34.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":615,"price":331.11,"value":203632.65,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 386 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":51222,"source":{"system":"sec-edgar","filing":"0000318154-26-000085","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000085/form4.xml","form_type":"4"}},{"id":9952,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10839,"kind":"person","name":"Bradway Robert A","position":1,"cik":"0001396482","reported_name":"Bradway Robert A","relationship":{"director":true,"officer":true,"officer_title":"Chairman, CEO and President"}}],"security":"Common Stock","published_at":"2026-05-11T23:39:11.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":2079,"price":331.11,"value":688377.69,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 1,273 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":505160,"source":{"system":"sec-edgar","filing":"0000318154-26-000084","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000084/form4.xml","form_type":"4"}},{"id":9953,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10840,"kind":"person","name":"Bradner James E.","position":1,"cik":"0002005159","reported_name":"Bradner James E.","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2026-05-11T23:36:55.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":446,"price":331.11,"value":147675.06,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 1,273 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":30016,"source":{"system":"sec-edgar","filing":"0000318154-26-000083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000083/form4.xml","form_type":"4"}},{"id":10039,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10840,"kind":"person","name":"Bradner James E.","position":1,"cik":"0002005159","reported_name":"Bradner James E.","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Nqso (Right to Buy)","published_at":"2026-05-08T01:14:26.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":21773,"price":329.59,"value":7176163.07,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027."}],"balance_after":21773,"derivative":{"exercise_price":329.59,"exercise_date":"2027-05-05","expiration_date":"2036-05-05","underlying":"Common Stock","underlying_shares":21773},"source":{"system":"sec-edgar","filing":"0000318154-26-000082","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000082/form4.xml","form_type":"4"}},{"id":10038,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10840,"kind":"person","name":"Bradner James E.","position":1,"cik":"0002005159","reported_name":"Bradner James E.","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2026-05-08T01:14:26.000Z","date":"2026-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":407,"price":329.59,"value":134143.13,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,332 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":30462,"source":{"system":"sec-edgar","filing":"0000318154-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000082/form4.xml","form_type":"4"}},{"id":10037,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10840,"kind":"person","name":"Bradner James E.","position":1,"cik":"0002005159","reported_name":"Bradner James E.","relationship":{"officer":true,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2026-05-08T01:14:26.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":3337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":30869,"source":{"system":"sec-edgar","filing":"0000318154-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000082/form4.xml","form_type":"4"}},{"id":10042,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10839,"kind":"person","name":"Bradway Robert A","position":1,"cik":"0001396482","reported_name":"Bradway Robert A","relationship":{"director":true,"officer":true,"officer_title":"Chairman, CEO and President"}}],"security":"Nqso (Right to Buy)","published_at":"2026-05-08T01:12:06.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":79176,"price":329.59,"value":26095617.84,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027."}],"balance_after":79176,"derivative":{"exercise_price":329.59,"exercise_date":"2027-05-05","expiration_date":"2036-05-05","underlying":"Common Stock","underlying_shares":79176},"source":{"system":"sec-edgar","filing":"0000318154-26-000081","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000081/form4.xml","form_type":"4"}},{"id":10041,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10839,"kind":"person","name":"Bradway Robert A","position":1,"cik":"0001396482","reported_name":"Bradway Robert A","relationship":{"director":true,"officer":true,"officer_title":"Chairman, CEO and President"}}],"security":"Common Stock","published_at":"2026-05-08T01:12:06.000Z","date":"2026-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1702,"price":329.59,"value":560962.18,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,520 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":507239,"source":{"system":"sec-edgar","filing":"0000318154-26-000081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000081/form4.xml","form_type":"4"}},{"id":10040,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10839,"kind":"person","name":"Bradway Robert A","position":1,"cik":"0001396482","reported_name":"Bradway Robert A","relationship":{"director":true,"officer":true,"officer_title":"Chairman, CEO and President"}}],"security":"Common Stock","published_at":"2026-05-08T01:12:06.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":12136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":508941,"source":{"system":"sec-edgar","filing":"0000318154-26-000081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000081/form4.xml","form_type":"4"}},{"id":10045,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Nqso (Right to Buy)","published_at":"2026-05-08T01:06:02.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":2969,"price":329.59,"value":978552.71,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027."}],"balance_after":2969,"derivative":{"exercise_price":329.59,"exercise_date":"2027-05-05","expiration_date":"2036-05-05","underlying":"Common Stock","underlying_shares":2969},"source":{"system":"sec-edgar","filing":"0000318154-26-000080","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000080/form4.xml","form_type":"4"}},{"id":10044,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-05-08T01:06:02.000Z","date":"2026-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":50,"price":329.59,"value":16479.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 45 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":4385,"source":{"system":"sec-edgar","filing":"0000318154-26-000080","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000080/form4.xml","form_type":"4"}},{"id":10043,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-05-08T01:06:02.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":4435,"source":{"system":"sec-edgar","filing":"0000318154-26-000080","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000080/form4.xml","form_type":"4"}},{"id":10048,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10838,"kind":"person","name":"Gordon Murdo","position":1,"cik":"0001642156","reported_name":"Gordon Murdo","relationship":{"officer":true,"officer_title":"EVP, Global Commercial Ops"}}],"security":"Nqso (Right to Buy)","published_at":"2026-05-08T01:01:54.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":23752,"price":329.59,"value":7828421.68,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027."}],"balance_after":23752,"derivative":{"exercise_price":329.59,"exercise_date":"2027-05-05","expiration_date":"2036-05-05","underlying":"Common Stock","underlying_shares":23752},"source":{"system":"sec-edgar","filing":"0000318154-26-000079","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000079/form4.xml","form_type":"4"}},{"id":10047,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10838,"kind":"person","name":"Gordon Murdo","position":1,"cik":"0001642156","reported_name":"Gordon Murdo","relationship":{"officer":true,"officer_title":"EVP, Global Commercial Ops"}}],"security":"Common Stock","published_at":"2026-05-08T01:01:54.000Z","date":"2026-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":502,"price":329.59,"value":165454.18,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 458 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":51837,"source":{"system":"sec-edgar","filing":"0000318154-26-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000079/form4.xml","form_type":"4"}},{"id":10046,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10838,"kind":"person","name":"Gordon Murdo","position":1,"cik":"0001642156","reported_name":"Gordon Murdo","relationship":{"officer":true,"officer_title":"EVP, Global Commercial Ops"}}],"security":"Common Stock","published_at":"2026-05-08T01:01:54.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":3640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":52339,"source":{"system":"sec-edgar","filing":"0000318154-26-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000079/form4.xml","form_type":"4"}},{"id":10051,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10837,"kind":"person","name":"Graham Jonathan P","position":1,"cik":"0001365306","reported_name":"Graham Jonathan P","relationship":{"officer":true,"officer_title":"EVP & Gen. Counsel & Sec."}}],"security":"Nqso (Right to Buy)","published_at":"2026-05-08T00:59:37.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":17022,"price":329.59,"value":5610280.98,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027."}],"balance_after":17022,"derivative":{"exercise_price":329.59,"exercise_date":"2027-05-05","expiration_date":"2036-05-05","underlying":"Common Stock","underlying_shares":17022},"source":{"system":"sec-edgar","filing":"0000318154-26-000078","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000078/form4.xml","form_type":"4"}},{"id":10050,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10837,"kind":"person","name":"Graham Jonathan P","position":1,"cik":"0001365306","reported_name":"Graham Jonathan P","relationship":{"officer":true,"officer_title":"EVP & Gen. Counsel & Sec."}}],"security":"Common Stock","published_at":"2026-05-08T00:59:37.000Z","date":"2026-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":408,"price":329.59,"value":134472.72,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 370 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":40211,"source":{"system":"sec-edgar","filing":"0000318154-26-000078","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000078/form4.xml","form_type":"4"}},{"id":10049,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10837,"kind":"person","name":"Graham Jonathan P","position":1,"cik":"0001365306","reported_name":"Graham Jonathan P","relationship":{"officer":true,"officer_title":"EVP & Gen. Counsel & Sec."}}],"security":"Common Stock","published_at":"2026-05-08T00:59:37.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":2609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":40619,"source":{"system":"sec-edgar","filing":"0000318154-26-000078","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000078/form4.xml","form_type":"4"}},{"id":10054,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10836,"kind":"person","name":"Griffith Peter H.","position":1,"cik":"0001798821","reported_name":"Griffith Peter H.","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Nqso (Right to Buy)","published_at":"2026-05-08T00:56:19.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":23752,"price":329.59,"value":7828421.68,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027."}],"balance_after":23752,"derivative":{"exercise_price":329.59,"exercise_date":"2027-05-05","expiration_date":"2036-05-05","underlying":"Common Stock","underlying_shares":23752},"source":{"system":"sec-edgar","filing":"0000318154-26-000077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000077/form4.xml","form_type":"4"}},{"id":10053,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10836,"kind":"person","name":"Griffith Peter H.","position":1,"cik":"0001798821","reported_name":"Griffith Peter H.","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-05-08T00:56:19.000Z","date":"2026-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":502,"price":329.59,"value":165454.18,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 424 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":50706,"source":{"system":"sec-edgar","filing":"0000318154-26-000077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000077/form4.xml","form_type":"4"}},{"id":10052,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10836,"kind":"person","name":"Griffith Peter H.","position":1,"cik":"0001798821","reported_name":"Griffith Peter H.","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-05-08T00:56:19.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":3640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":51208,"source":{"system":"sec-edgar","filing":"0000318154-26-000077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000077/form4.xml","form_type":"4"}},{"id":10057,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Nqso (Right to Buy)","published_at":"2026-05-08T00:54:27.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":3167,"price":329.59,"value":1043811.53,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027."}],"balance_after":6334,"derivative":{"exercise_price":329.59,"exercise_date":"2027-05-05","expiration_date":"2036-05-05","underlying":"Common Stock","underlying_shares":3167},"source":{"system":"sec-edgar","filing":"0000318154-26-000076","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000076/form4.xml","form_type":"4"}},{"id":10056,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-05-08T00:54:27.000Z","date":"2026-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":76,"price":329.59,"value":25048.84,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 68 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":7418,"source":{"system":"sec-edgar","filing":"0000318154-26-000076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000076/form4.xml","form_type":"4"}},{"id":10055,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-05-08T00:54:27.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":7494,"source":{"system":"sec-edgar","filing":"0000318154-26-000076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000076/form4.xml","form_type":"4"}},{"id":10060,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10467,"kind":"person","name":"Khosla Rachna","position":1,"cik":"0001881332","reported_name":"Khosla Rachna","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Nqso (Right to Buy)","published_at":"2026-05-08T00:52:32.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":3266,"price":329.59,"value":1076440.94,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027."}],"balance_after":3266,"derivative":{"exercise_price":329.59,"exercise_date":"2027-05-05","expiration_date":"2036-05-05","underlying":"Common Stock","underlying_shares":3266},"source":{"system":"sec-edgar","filing":"0000318154-26-000075","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000075/form4.xml","form_type":"4"}},{"id":10059,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10467,"kind":"person","name":"Khosla Rachna","position":1,"cik":"0001881332","reported_name":"Khosla Rachna","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2026-05-08T00:52:32.000Z","date":"2026-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":79,"price":329.59,"value":26037.61,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 69 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":8487,"source":{"system":"sec-edgar","filing":"0000318154-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000075/form4.xml","form_type":"4"}},{"id":10058,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10467,"kind":"person","name":"Khosla Rachna","position":1,"cik":"0001881332","reported_name":"Khosla Rachna","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2026-05-08T00:52:32.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":8566,"source":{"system":"sec-edgar","filing":"0000318154-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000075/form4.xml","form_type":"4"}},{"id":10063,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10493,"kind":"person","name":"Miller Derek","position":1,"cik":"0001917312","reported_name":"Miller Derek","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Nqso (Right to Buy)","published_at":"2026-05-08T00:50:41.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":5938,"price":329.59,"value":1957105.42,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027."}],"balance_after":5938,"derivative":{"exercise_price":329.59,"exercise_date":"2027-05-05","expiration_date":"2036-05-05","underlying":"Common Stock","underlying_shares":5938},"source":{"system":"sec-edgar","filing":"0000318154-26-000074","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000074/form4.xml","form_type":"4"}},{"id":10062,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10493,"kind":"person","name":"Miller Derek","position":1,"cik":"0001917312","reported_name":"Miller Derek","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-05-08T00:50:41.000Z","date":"2026-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":123,"price":329.59,"value":40539.57,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 116 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":12595,"source":{"system":"sec-edgar","filing":"0000318154-26-000074","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000074/form4.xml","form_type":"4"}},{"id":10061,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10493,"kind":"person","name":"Miller Derek","position":1,"cik":"0001917312","reported_name":"Miller Derek","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-05-08T00:50:41.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":12718,"source":{"system":"sec-edgar","filing":"0000318154-26-000074","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000074/form4.xml","form_type":"4"}},{"id":10066,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Nqso (Right to Buy)","published_at":"2026-05-08T00:48:43.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":19002,"price":329.59,"value":6262869.18,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027, subject to proration based on the number of completed months of active employment in 2026."}],"balance_after":19002,"derivative":{"exercise_price":329.59,"exercise_date":"2027-05-05","expiration_date":"2036-05-05","underlying":"Common Stock","underlying_shares":19002},"source":{"system":"sec-edgar","filing":"0000318154-26-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000073/form4.xml","form_type":"4"}},{"id":10065,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-05-08T00:48:43.000Z","date":"2026-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":454,"price":329.59,"value":149633.86,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 415 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":42812,"source":{"system":"sec-edgar","filing":"0000318154-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000073/form4.xml","form_type":"4"}},{"id":10064,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-05-08T00:48:43.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":2912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027, subject to proration based on the number of completed months of active employment in 2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":43266,"source":{"system":"sec-edgar","filing":"0000318154-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000073/form4.xml","form_type":"4"}},{"id":10069,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10834,"kind":"person","name":"Santos Esteban","position":1,"cik":"0001677950","reported_name":"Santos Esteban","relationship":{"officer":true,"officer_title":"EVP, Operations"}}],"security":"Nqso (Right to Buy)","published_at":"2026-05-08T00:46:24.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":17814,"price":329.59,"value":5871316.26,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027."}],"balance_after":17814,"derivative":{"exercise_price":329.59,"exercise_date":"2027-05-05","expiration_date":"2036-05-05","underlying":"Common Stock","underlying_shares":17814},"source":{"system":"sec-edgar","filing":"0000318154-26-000072","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000072/form4.xml","form_type":"4"}},{"id":10068,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10834,"kind":"person","name":"Santos Esteban","position":1,"cik":"0001677950","reported_name":"Santos Esteban","relationship":{"officer":true,"officer_title":"EVP, Operations"}}],"security":"Common Stock","published_at":"2026-05-08T00:46:24.000Z","date":"2026-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":427,"price":329.59,"value":140734.93,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 388 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":83369,"source":{"system":"sec-edgar","filing":"0000318154-26-000072","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000072/form4.xml","form_type":"4"}},{"id":10067,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10834,"kind":"person","name":"Santos Esteban","position":1,"cik":"0001677950","reported_name":"Santos Esteban","relationship":{"officer":true,"officer_title":"EVP, Operations"}}],"security":"Common Stock","published_at":"2026-05-08T00:46:24.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":2730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":83796,"source":{"system":"sec-edgar","filing":"0000318154-26-000072","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000072/form4.xml","form_type":"4"}},{"id":10070,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-08T00:40:36.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":106.1925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 418 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":6693.7361,"source":{"system":"sec-edgar","filing":"0000318154-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000071/form4.xml","form_type":"4"}},{"id":10071,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10489,"kind":"person","name":"HOLLEY CHARLES M","position":1,"cik":"0001216478","reported_name":"HOLLEY CHARLES M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-08T00:38:34.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":128.9481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 1,564 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":12134.0331,"source":{"system":"sec-edgar","filing":"0000318154-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000070/form4.xml","form_type":"4"}},{"id":10072,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10490,"kind":"person","name":"Drake Michael V","position":1,"cik":"0001938942","reported_name":"Drake Michael V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-08T00:36:28.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":79.6444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 339 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":5109.2869,"source":{"system":"sec-edgar","filing":"0000318154-26-000069","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000069/form4.xml","form_type":"4"}},{"id":10281,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10834,"kind":"person","name":"Santos Esteban","position":1,"cik":"0001677950","reported_name":"Santos Esteban","relationship":{"officer":true,"officer_title":"EVP, Operations"}}],"security":"Common Stock","published_at":"2026-05-06T00:13:56.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":641,"price":329.82,"value":211414.62,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 414 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":81066,"source":{"system":"sec-edgar","filing":"0000318154-26-000068","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000068/form4.xml","form_type":"4"}},{"id":10280,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10834,"kind":"person","name":"Santos Esteban","position":1,"cik":"0001677950","reported_name":"Santos Esteban","relationship":{"officer":true,"officer_title":"EVP, Operations"}}],"security":"Common Stock","published_at":"2026-05-06T00:13:56.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":697,"price":329.82,"value":229884.54,"ownership":{"direct":true},"balance_after":81707,"source":{"system":"sec-edgar","filing":"0000318154-26-000068","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000068/form4.xml","form_type":"4"}},{"id":10279,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-05-06T00:12:54.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":687,"price":329.82,"value":226586.34,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 442 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":40354,"source":{"system":"sec-edgar","filing":"0000318154-26-000067","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000067/form4.xml","form_type":"4"}},{"id":10278,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10835,"kind":"person","name":"REESE DAVID M","position":1,"cik":"0001748434","reported_name":"REESE DAVID M","relationship":{"officer":true,"officer_title":"EVP & Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-05-06T00:12:54.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":746,"price":329.82,"value":246045.72,"ownership":{"direct":true},"balance_after":41041,"source":{"system":"sec-edgar","filing":"0000318154-26-000067","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000067/form4.xml","form_type":"4"}},{"id":10283,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10493,"kind":"person","name":"Miller Derek","position":1,"cik":"0001917312","reported_name":"Miller Derek","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-05-06T00:11:56.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":198,"price":329.82,"value":65304.36,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 123 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":11808,"source":{"system":"sec-edgar","filing":"0000318154-26-000066","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000066/form4.xml","form_type":"4"}},{"id":10282,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10493,"kind":"person","name":"Miller Derek","position":1,"cik":"0001917312","reported_name":"Miller Derek","relationship":{"officer":true,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-05-06T00:11:56.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":167,"price":329.82,"value":55079.94,"ownership":{"direct":true},"balance_after":12006,"source":{"system":"sec-edgar","filing":"0000318154-26-000066","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000066/form4.xml","form_type":"4"}},{"id":10285,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10467,"kind":"person","name":"Khosla Rachna","position":1,"cik":"0001881332","reported_name":"Khosla Rachna","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2026-05-06T00:11:04.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":108,"price":329.82,"value":35620.56,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 73 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":8066,"source":{"system":"sec-edgar","filing":"0000318154-26-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000065/form4.xml","form_type":"4"}},{"id":10284,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10467,"kind":"person","name":"Khosla Rachna","position":1,"cik":"0001881332","reported_name":"Khosla Rachna","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2026-05-06T00:11:04.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":117,"price":329.82,"value":38588.94,"ownership":{"direct":true},"balance_after":8174,"source":{"system":"sec-edgar","filing":"0000318154-26-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000065/form4.xml","form_type":"4"}},{"id":10288,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-05-06T00:09:56.000Z","date":"2026-05-04","kind":"sale","planned":false,"acquired":false,"shares":1237,"price":323.7272,"value":400450.5464,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is an average price of $323.7272 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 72 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":7009,"source":{"system":"sec-edgar","filing":"0000318154-26-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000064/form4.xml","form_type":"4"}},{"id":10287,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-05-06T00:09:56.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":116,"price":329.82,"value":38259.12,"ownership":{"direct":true},"balance_after":8246,"source":{"system":"sec-edgar","filing":"0000318154-26-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000064/form4.xml","form_type":"4"}},{"id":10286,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10494,"kind":"person","name":"Grygiel Nancy A.","position":1,"cik":"0001816414","reported_name":"Grygiel Nancy A.","relationship":{"officer":true,"officer_title":"SVP & CCO"}}],"security":"Common Stock","published_at":"2026-05-06T00:09:56.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":126,"price":329.82,"value":41557.32,"ownership":{"direct":true},"balance_after":8362,"source":{"system":"sec-edgar","filing":"0000318154-26-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000064/form4.xml","form_type":"4"}},{"id":10290,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10836,"kind":"person","name":"Griffith Peter H.","position":1,"cik":"0001798821","reported_name":"Griffith Peter H.","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-05-06T00:08:46.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":687,"price":329.82,"value":226586.34,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 454 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":47568,"source":{"system":"sec-edgar","filing":"0000318154-26-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000063/form4.xml","form_type":"4"}},{"id":10289,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10836,"kind":"person","name":"Griffith Peter H.","position":1,"cik":"0001798821","reported_name":"Griffith Peter H.","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-05-06T00:08:46.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":746,"price":329.82,"value":246045.72,"ownership":{"direct":true},"balance_after":48255,"source":{"system":"sec-edgar","filing":"0000318154-26-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000063/form4.xml","form_type":"4"}},{"id":10292,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10837,"kind":"person","name":"Graham Jonathan P","position":1,"cik":"0001365306","reported_name":"Graham Jonathan P","relationship":{"officer":true,"officer_title":"EVP & Gen. Counsel & Sec."}}],"security":"Common Stock","published_at":"2026-05-06T00:07:54.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":610,"price":329.82,"value":201190.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 395 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":38010,"source":{"system":"sec-edgar","filing":"0000318154-26-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000062/form4.xml","form_type":"4"}},{"id":10291,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10837,"kind":"person","name":"Graham Jonathan P","position":1,"cik":"0001365306","reported_name":"Graham Jonathan P","relationship":{"officer":true,"officer_title":"EVP & Gen. Counsel & Sec."}}],"security":"Common Stock","published_at":"2026-05-06T00:07:54.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":647,"price":329.82,"value":213393.54,"ownership":{"direct":true},"balance_after":38620,"source":{"system":"sec-edgar","filing":"0000318154-26-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000062/form4.xml","form_type":"4"}},{"id":10294,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10838,"kind":"person","name":"Gordon Murdo","position":1,"cik":"0001642156","reported_name":"Gordon Murdo","relationship":{"officer":true,"officer_title":"EVP, Global Commercial Ops"}}],"security":"Common Stock","published_at":"2026-05-06T00:06:59.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":763,"price":329.82,"value":251652.66,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 488 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":48699,"source":{"system":"sec-edgar","filing":"0000318154-26-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000061/form4.xml","form_type":"4"}},{"id":10293,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10838,"kind":"person","name":"Gordon Murdo","position":1,"cik":"0001642156","reported_name":"Gordon Murdo","relationship":{"officer":true,"officer_title":"EVP, Global Commercial Ops"}}],"security":"Common Stock","published_at":"2026-05-06T00:06:59.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":830,"price":329.82,"value":273750.6,"ownership":{"direct":true},"balance_after":49462,"source":{"system":"sec-edgar","filing":"0000318154-26-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000061/form4.xml","form_type":"4"}},{"id":10296,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-05-06T00:05:41.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":38,"price":329.82,"value":12533.16,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 49 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":3980,"source":{"system":"sec-edgar","filing":"0000318154-26-000060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000060/form4.xml","form_type":"4"}},{"id":10295,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10477,"kind":"person","name":"Busch Matthew C.","position":1,"cik":"0001987926","reported_name":"Busch Matthew C.","relationship":{"officer":true,"officer_title":"VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2026-05-06T00:05:41.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":30,"price":329.82,"value":9894.6,"ownership":{"direct":true},"balance_after":4018,"source":{"system":"sec-edgar","filing":"0000318154-26-000060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000060/form4.xml","form_type":"4"}},{"id":10298,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10839,"kind":"person","name":"Bradway Robert A","position":1,"cik":"0001396482","reported_name":"Bradway Robert A","relationship":{"director":true,"officer":true,"officer_title":"Chairman, CEO and President"}}],"security":"Common Stock","published_at":"2026-05-05T23:52:31.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2426,"price":329.82,"value":800143.32,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 1,624 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":496805,"source":{"system":"sec-edgar","filing":"0000318154-26-000058","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000058/form4.xml","form_type":"4"}},{"id":10297,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10839,"kind":"person","name":"Bradway Robert A","position":1,"cik":"0001396482","reported_name":"Bradway Robert A","relationship":{"director":true,"officer":true,"officer_title":"Chairman, CEO and President"}}],"security":"Common Stock","published_at":"2026-05-05T23:52:31.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2631,"price":329.82,"value":867756.42,"ownership":{"direct":true},"balance_after":499231,"source":{"system":"sec-edgar","filing":"0000318154-26-000058","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000058/form4.xml","form_type":"4"}},{"id":11780,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10834,"kind":"person","name":"Santos Esteban","position":1,"cik":"0001677950","reported_name":"Santos Esteban","relationship":{"officer":true,"officer_title":"EVP, Operations"}}],"security":"Common Stock","published_at":"2026-03-19T00:39:41.000Z","date":"2026-03-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":5621,"price":366.21,"value":2058466.41,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 696 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":82404,"source":{"system":"sec-edgar","filing":"0000318154-26-000033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000033/form4.xml","form_type":"4"}}],"next_cursor":"2026-03-19T00:39:41.000000Z,11780"}